NEW YORK (GenomeWeb News) — Shares in Sequenom were up 9.51 percent, or $.45, at $5.18, in mid-afternoon trading today after the company said it will work with Qiagen to develop a preanalytical product to enrich nucleic acids for prenatal diagnostics.
 
As GenomeWeb News reported this morning, Sequenom will retain commercial rights to any tests the companies develop under the partnership.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.